Citigroup
TMDX icon

Citigroup’s Transmedics TMDX Stock Holding History

Citigroup’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.6M Buy
386,066
+28,685
+8% +$2.43M 0.01% 1032
2026
Q1 		$35.5M Buy
357,381
+285,337
+396% +$37.2M 0.02% 787
2025
Q4 		$8.76M Sell
72,044
-4,741
-6% -$595K ﹤0.01% 1638
2025
Q3 		$8.62M Buy
76,785
+33,414
+77% +$3.91M ﹤0.01% 1604
2025
Q2 		$5.81M Sell
43,371
-4,916
-10% -$540K ﹤0.01% 1764
2025
Q1 		$3.25M Buy
48,287
+2,486
+5% +$171K ﹤0.01% 2289
2024
Q4 		$2.86M Buy
45,801
+3,725
+9% +$347K ﹤0.01% 2498
2024
Q3 		$6.61M Buy
42,076
+32,552
+342% +$5.02M ﹤0.01% 1623
2024
Q2 		$1.43M Buy
9,524
+3,790
+66% +$455K ﹤0.01% 2618
2024
Q1 		$424K Sell
5,734
-5,638
-50% -$465K ﹤0.01% 3672
2023
Q4 		$898K Buy
11,372
+4,390
+63% +$265K ﹤0.01% 2917
2023
Q3 		$382K Sell
6,982
-5,573
-44% -$401K ﹤0.01% 3266
2023
Q2 		$1.05M Buy
12,555
+10,216
+437% +$782K ﹤0.01% 2809
2023
Q1 		$177K Buy
2,339
+1,134
+94% +$78.4K ﹤0.01% 3789
2022
Q4 		$74.4K Buy
1,205
+8
+0.7% +$425 ﹤0.01% 4140
2022
Q3 		$50K Sell
1,197
-1,202
-50% -$52.3K ﹤0.01% 4389
2022
Q2 		$75K Buy
2,399
+670
+39% +$17.9K ﹤0.01% 4356
2022
Q1 		$47K Sell
1,729
-5,304
-75% -$95K ﹤0.01% 4754
2021
Q4 		$135K Buy
7,033
+3,691
+110% +$92.5K ﹤0.01% 4573
2021
Q3 		$111K Buy
3,342
+1,483
+80% +$45.3K ﹤0.01% 4380
2021
Q2 		$62K Sell
1,859
-1,928
-51% -$53.4K ﹤0.01% 4715
2021
Q1 		$157K Sell
3,787
-1,135
-23% -$34.9K ﹤0.01% 4140
2020
Q4 		$98K Buy
4,922
+3,715
+308% +$55K ﹤0.01% 5549
2020
Q3 		$17K Sell
1,207
-1,466
-55% -$25.1K ﹤0.01% 6308
2020
Q2 		$48K Sell
2,673
-1,441
-35% -$22.5K ﹤0.01% 6041
2020
Q1 		$50K Buy
4,114
+1,258
+44% +$21.1K ﹤0.01% 5980
2019
Q4 		$54K Buy
2,856
+2,552
+839% +$46.9K ﹤0.01% 6245
2019
Q3 		$7K Sell
304
-1,521
-83% -$36.5K ﹤0.01% 7228
2019
Q2 		$53K Buy
+1,825
New +$49.8K ﹤0.01% 6422

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Citigroup's TMDX Position: Q2 2026 in Review

Citigroup increased its Transmedics (TMDX) stake by 8% in Q2 2026, buying an estimated $2.43M and bringing the position to 386,066 shares worth $25.6M. The position accounts for 0.01% of the portfolio, ranked #1032.

Citigroup first reported a position in TMDX in Q2 2019 and has held it in 29 quarters since. The position peaked at $35.5M in Q1 2026. 374 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Citigroup held 386,066 shares of Transmedics worth $25.6M as of Q2 2026.
  • Citigroup bought 28,685 Transmedics shares in Q2 2026, an estimated $2.43M.
  • Transmedics made up 0.01% of Citigroup's portfolio in Q2 2026, its #1032 holding.
  • Citigroup first reported a position in Transmedics in Q2 2019 and has held it in 29 quarters since.
  • Citigroup's Transmedics position peaked at $35.5M in Q1 2026.
  • 374 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.